Efficacy and safety of Huashi Baidu granule plus Nirmatrelvir-Ritonavir combination therapy in patients with high-risk factors infected with Omicron (B.1.1.529): A multi-arm single-center, open-label, randomized controlled trial

Zhuo Yu, Yanxi Zheng, Bowu Chen, Jia Lv, Xiaojun Zhu, Binyi Shang, Yuping Xv, Tao Ru, Yanbing Yang, Jun Cong, Dan Li, Huan Wu, Wenchao Qv, Xiyi Zhang, Chengbin Xv, Hai Feng, Wei-An Yuan, Yueqiu Gao